Ameet Nathwani

Ameet is a global biotechnology and pharmaceutical executive with 30+ years of leadership experience across drug development, corporate strategy, digital transformation, and medical innovation.

He currently serves as CEO of Dewpoint Therapeutics, a company pioneering drug discovery through biomolecular condensates. Previously, he was Chief Medical Officer and Chief Digital Officer at Sanofi, and also held senior leadership positions at Novartis and GSK.

His career highlights include leading more than 20 global development programs, securing 16+ product approvals, and advancing AI-driven real-world evidence platforms, digital therapeutics, and AI-enhanced drug discovery.

Based in Switzerland, Ameet will be a key contributor to Smile Sail’s investments in Health & Pharma Software, AI, and IT Services.